Gregory J. Nadolski, MD
Interventional Radiology
Accepting new patients
Sees patients age 18 and up
Penn Interventional Radiology HUP
View 2 additional locations
Penn Medicine Provider

About me

  • Co-Director, Penn Image-Guided Interventions (PIGI) Laboratory
  • Chair, Interventional Radiology Resident Selection Committee
  • Associate Professor of Radiology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Indiana University Hospital
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

What my patients think about me

Average Rating

187 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
best doctor i have ever had
October 2025
everything was great
October 2025
he is very personable and explains things in detail
September 2025
very precise description of my problem along with information to getting additional treatment

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Nadolski is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

M Sheng, T Gade, G Nadolski Management of Hepatic Metastases from Colorectal Cancer , Digestive Disease Interventions (Book): 2026


Elisabeth R Seyferth 1, Gregory J Nadolski 1, Jeffrey I Mondschein 1, Ryan M Cobb 1, Scott O Trerotola 1 Factors affecting the difficulty of transurethral double J stent removal in patients with renal transplants , Diagnostic and Interventional Radiology: 2025


M Angela Aznar 1, Charly R Good 2, Julie S Barber-Rotenberg 3, Sangya Agarwal 3, Wesley Wilson 3, Alex Watts 4, Zhen Zhang 2, Donna Gonzales 3, Greg Donahue 2, Wei-Ting Hwang 4, Austin K Rennels 3, Andrew J Rech 3, Shunichiro Kuramitsu 3, Hua Huang 5, Karl M Glastad 2, Katherine A Alexander 2, Gabriela Plesa 3, Emily Dowd 3, Andrea Brennan 3, Donald L Siegel 1, Janos Tanyi 6, Andrew Haas 7, Drew A Torigian 8, Gregory Nadolski 8, Vanessa E Gonzalez 3, Elizabeth O Hexner 9, Joseph A Fraietta 10, Julie K Jadlowsky 3, Regina M Young 11, Shelley L Berger 12, Carl H June 13, Mark H O'Hara 14 Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer , Cell Reports Medicine, 6(9): 2025


Alexey Gurevich 1, Gregory J Nadolski 1, Ansar Z Vance 1, Ryan-Assaad El-Ghazal 2, Raphael Cohen 3, Timothy W I Clark 1, Matthew L Hung 4 Tunneled dialysis catheter placement in intensive care unit patients: influence of catheter tip design on clinical performance , CVIR Endovascular: 2025


Hung ML, Jairam A, Carr M, Berman ZT, Taddonio M, Minocha J, Aryafar H, Mondschein JI, Soulen MC, Nadolski GJ, Redmond J. Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound vs fluoroscopic guidance: A dual-institution retrospective comparative study , World Journal of Hepatology, 17(5): 2025


Moon HE, Hur S, Moon J, Lee SH, Choi H, Ratnam L, Nadolski G, Itkin M. Lymphatic Embolization for Primary Genital Lymphorrhea and Chylous Reflux-Related Lower Limb Lymphedema , JVIR, 36(5): 2025


Cornman-Homonoff J, Fortune BE, Kolli KP, Kothary N, Nadolski G, Thornburg BG, Verma S, Madoff DC Management of Ascites: AJR Expert Panel Narrative Review. , AJR Am J Roentgenology: 2025


Gurevich A, Islam A, Wakim J, Yarsky E, Kiefer R, El-Ghazal R, McClung G, Cormode DP, Nadolski GJ, Avritscher R, Hunt SJ, Gade TPF Comparison of Liquid with Particle Embolics in a Translational Rat Model of Hepatocellular Carcinoma: Histologic and Radiographic Responses , JVIR, 36(4): 2025


K. Rao, S. Kayfan, R. Romano, ...G. Nadolski, R. Cobb, S. Hunt, M. Soulen Premedication with NK-1 Antagonists and COX-2 Inhibitors Improves Same-Day Discharge Rates Following Chemoembolization for Hepatocellular Carcinoma and Neuroendocrine Liver Metastasis , JVIR, 36(3S): 2025,S109-110


J. Kus,G. Nadolski,S. Hunt,...S. Shamimi-Noori,M. Soulen,D. DePietro Utility of Alpha-Fetoprotein (AFP) Monitoring After Y-90 Radioembolization of Hepatocellular Carcinoma in Non-AFP Producers , JVIR, 36(3S): 2025,S199-200